Prevalence of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2643-2645

  Eun, Sil Kim ^a   Jeong, Jin Yong ^a   Jun, Jae Bum ^a   Choi, Sang Ho ^a   Lee, Sang Oh ^a   Kim, Mi Na ^b   Jun, Hee Woo ^a   Yang, Soo Kim ^a,b  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M 1; BETA LACTAMASE OXA 1; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

AAC6' IB CR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QNRS GENE; RANDOM AMPLIFIED POLYMORPHIC DNA;

ACETYLTRANSFERASES; BETA-LACTAMASES; CIPROFLOXACIN; CONJUGATION, GENETIC; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 67049145548     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01534-08     Document Type: Article

References (14)

1. Aslam, M., F. Nattress, G. Greer, C. Yost, C. Gill, and L. McMullen. 2003. Origin of contamination and genetic diversity of Escherichia coli in beef cattle. Appl. Environ. Microbiol. 69:2794-2799.
2. Cordeiro, N. F., L. Robino, J. Medina, V. Seija, I. Bado, V. García, M. Berro, J. Pontet, L. Lo′pez, C. Bazet, G. Rieppi, G. Gutkind, J. A. Ayala, and R. Vignoli. 2008. Ciprofloxacin-resistant enterobacteria harboring the aac(6′)-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay. Antimicrob. Agents Chemother. 52:806-807.
3. Ho, P. L., R. H. Shek, K. H. Chow, R. S. Duan, G. C. Mak, E. L. Lai, W. C. Yam, K. W. Tsang, and W. M. Lai. 2005. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J. Antimicrob. Chemother. 55:326-332.
4. Jeong, J. Y., H. J. Yoon, E. S. Kim, Y. Lee, S. H. Choi, N. J. Kim, J. H. Woo, and Y. S. Kim. 2005. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob. Agents Chemother. 49:2522-2524.
5. Kim, J., and Y. M. Lim. 2005. Prevalence of derepressed AmpC mutants and extended-spectrum β-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. Antimicrob. Agents Chemother. 43:2452-2455.
6. Machado, E., T. M. Coque, R. Cantón, F. Baquero, J. C. Sousa, and L. Peixe. 2006. Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob. Agents Chemother. 50:3220-3221.
7. Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799. (Pubitemid 28112342)
8. Pai, H., M. R. Seo, and T. Y. Choi. 2007. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 51:366-368. (Pubitemid 46047732)
9. Park, C. H., A. Robicsek, G. A. Jacoby, D. Sahm, and D. C. Hooper. 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955.
10. Park, Y. J., S. Y. Park, E. J. Oh, J. J. Park, K. Y. Lee, G. J. Woo, and K. Lee. 2005. Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn. Microbiol. Infect. Dis. 51:265-269.
11. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.
12. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.
13. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.
14. Wu, J. J., W. C. Ko, H. M. Wu, and J. J. Yan. 2008. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005. J. Antimicrob. Chemother. 61:1234-1239.